FEATURES

FAMILY

DESCRIPTION

Also known as TAF4_HUMAN, TAF4, TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135. Part of the TFIID complex, a multimeric protein complex that plays a central role in mediating promoter responses to various activators and repressors. Potentiates transcriptional activation by the AF-2S of the retinoic acid, vitamin D3 and thyroid hormone. TFIID is composed of TATA binding protein (TBP) and a number of TBP-associated factors (TAFs). Component of the TFTC-HAT complex, at least composed of TAF5L, TAF6L, TADA3L, SUPT3H, TAF2, TAF4, TAF5, GCN5L2/GCN5, TAF10 and TRRAP. Component of some MLL1/MLL complex, at least composed of the core components KMT2A/MLL1, ASH2L, HCFC1/HCF1, WDR5 and RBBP5, as well as the facultative components BAP18, CHD8, E2F6, HSP70, INO80C, KANSL1, LAS1L, MAX, MCRS1, MGA, MYST1/MOF, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A, RUVB2/TIP49B, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10. Interacts with ATF7; the interaction inhibits ATF7-mediated tranactivation.

Also known as TAF4_HUMAN, TAF4, TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135. Part of the TFIID complex, a multimeric protein complex that plays a central role in mediating promoter responses to va ...

EXTERNAL LINKS

TAF4

Mutations

Mutation(s) distribution

Mutations table